,

HUMAN Diagnostics Announces the Launch of its Next Generation Clinical Chemistry Instruments at Medlab Middle East 2025

Wiesbaden, Germany – February 1, 2025 – HUMAN Diagnostics, a global player in in vitro diagnostics, announces the launch of its advanced clinical chemistry instruments,  scheduled to debut at Medlab Middle East in Dubai, from February 3–6, 2025. This  milestone reflects HUMAN’s commitment to delivering innovative and reliable  diagnostic solutions that meet the needs of modern laboratories worldwide. 

The launch is under the motto “Primed for Precision. Built for Performance” and will  spotlight the next-generation HumaStar 300SR, HumaStar 200, and the HumaLyzer  Primus NG, offering laboratories cutting-edge performance, enhanced efficiency, and  robust reliability. These instruments cater to diverse throughput needs, empowering  labs to deliver accurate and timely results critical to patient care. 

Dr. Christine Hettmann-Dreuw, VP Marketing & Strategic Purchase at HUMAN Diagnostics

“HUMAN’s clinical chemistry instruments have long been trusted for their precision and  reliability. With this launch, we’re setting new standards for laboratory diagnostics by  combining German engineering excellence with the latest technological advancements,”  said Dr. Christine Hettmann-Dreuw, VP Marketing & Strategic Purchase at HUMAN Diagnostics. 

Main updates to the newly introduced instruments 

HumaStar 300SR and HumaStar 200: The refined instruments offer improved  performance and reliability with an advanced cuvette wash station and, now  new, clot detection (HumaStar 300SR only). The upgraded pipetting unit ensures  higher precision for low volumes and better repeatability, while V-shaped  reaction cuvettes reduce reagent use and operating costs.  

Additionally, an integrated 2D barcode scanner simplifies the import of QC and  calibration target values, streamlining operations; the 3-color LED status  illumination provides intuitive and easy monitoring. 

HumaLyzer Primus NG: A user-friendly, semi-automated solution ideal for  laboratories in resource-limited settings with a large 7-inch touchscreen  interface enhancing usability.

Visitors to Medlab ME 2025 are invited to explore these next-gen instruments at  HUMAN’s booth #Z4.D20, where live demonstrations will showcase their capabilities  and ease of use. 

HUMAN Diagnostics has been at the forefront of empowering healthcare professionals  globally for over 50 years. By combining German quality standards with a commitment  to innovation, HUMAN continues to provide laboratories with solutions that improve  efficiency, enhance diagnostic confidence, and support equitable access to healthcare. 

For more information about the product launch or the company itself, visit  www.human.de

More Articles from the Medical Industry

HUMAN Diagnostics Announces the Launch of its Next Generation Clinical Chemistry Instruments at Medlab Middle East 2025

Wiesbaden, Germany – February 1, 2025 – HUMAN Diagnostics, a global player in in vitro diagnostics, announces the launch of …

Ireland’s Healthcare Pioneers Set to Transform Middle East Healthcare at Arab Health 2025

19 Irish companies, supported by Enterprise Ireland, to present cutting-edge medtech and digital healthcare solutions at Arab Health 2025. Major …

Fujifilm showcases its latest solutions for early detection and intervention at Arab Health 2025

The company’s cutting-edge healthcare solutions strongly align with the UAE’s goal to establish an innovative, state-of-the-art healthcare system highlighted in …

Arab Health to host record international participation as the global consumer healthcare market to reach US$780 billion by 2030

Statistics from Verified Market Research have revealed the global healthcare market could be worth upwards of US$780 billion by 2028, …
Share via
Copy link